Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics
Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to $950 million as per the latest pharma acquisition news. Rodin Therapeutics is engaged in developing novel, small molecules for the treatment of synaptopathies. Alkermes acquisition of Rodin Therapeutics is said […]